Abstract: A method for extracting uranium (VI) from an aqueous solution including phosphoric acid, which includes placing the aqueous solution 5 in contact with an organic material, followed by separating the aqueous solution and the organic material. The organic material includes a solid polymer substrate impregnated with a compound having the following general formula (I): The invention also relates to a method for retrieving uranium (VI) from an aqueous solution including phosphoric acid.

Abstract: An organic material which includes a solid polymer substrate onto which molecules having the following general formula (I) are grafted: The invention also relates to the use of the organic material to extract the uranium (VI) from an aqueous acid solution, to associated methods for extracting and retrieving uranium (VI) as well as to a molecule which is a precursor of the organic material. The disclosure also relates to the use of the organic material to extract the uranium (VI) from an aqueous acid solution, to associated methods for extracting and retrieving uranium (VI) as well as to a molecule which is a precursor of the organic material.

Abstract: The invention relates to a process for producing 228Th from a natural thorium salt, which comprises in succession: a) the separation of the radium from the other radioelements present in this salt, by at least one coprecipitation of the radium by barium sulphate, this coprecipitation comprising: i) the addition of sulphuric acid and a barium salt to an aqueous solution of said natural thorium salt in order to form a barium-radium sulphate coprecipitate and ii) the separation of the coprecipitate from the medium in which it has formed; b) the extraction of the thorium 228 coming from the decay of radium 228 from the coprecipitate thus separated; and, optionally c) the purification and concentration of the 228Th thus extracted. Applications: manufacture of radiopharmaceutical products useful in nuclear medicine, in particular in radioimmunotherapy for the treatment of cancers and AIDS.

Abstract: The invention relates to a process for producing 228Th from a natural thorium salt, which comprises in succession: a) the separation of the radium from the other radioelements present in this salt, by at least one coprecipitation of the radium by barium sulphate, this coprecipitation comprising: i) the addition of sulphuric acid and a barium salt to an aqueous solution of said natural thorium salt in order to form a barium-radium sulphate coprecipitate and ii) the separation of the coprecipitate from the medium in which it has formed; b) the extraction of the thorium 228 coming from the decay of radium 228 from the coprecipitate thus separated; and, optionally c) the purification and concentration of the 228Th thus extracted. Applications: manufacture of radiopharmaceutical products useful in nuclear medicine, in particular in radioimmunotherapy for the treatment of cancers and AIDS.